ENTA icon

Enanta Pharmaceuticals
ENTA

Overview Fund Activity

144 hedge funds and large institutions have $805M invested in Enanta Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 64 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
144
Holders Change
-2
Holders Change %
-1.37%
% of All Funds
2.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
43
Reduced
64
Closed
13
Calls
$4.12M
Puts
$440K
Net Calls
+$3.68M
Net Calls Change
-$6.7M

Top Buyers

1
B
1
Braidwell
Connecticut
$42M
2
PAMS
2
Pictet Asset Management (Switzerland)
Switzerland
$11M
3
Invesco
3
Invesco
Georgia
$12.2M
4
Citadel Advisors
4
Citadel Advisors
Florida
$11.8M
5
Bank of America
5
Bank of America
North Carolina
$9.01M

Top Sellers

1
State Street
1
State Street
Massachusetts
$48.6M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$4.86M
3
CCM
3
Camber Capital Management
Massachusetts
$0
4
TCM
4
Tang Capital Management
California
$3.64M
5
Norges Bank
5
Norges Bank
Norway
$4.96M
Name Holding Trade Value Shares
Change 		Shares
Change %
Axa
151
Axa
France
– -$288K -6,200 Closed
ProShare Advisors
152
ProShare Advisors
Maryland
– -$224K -4,808 Closed
D.E. Shaw & Co
153
D.E. Shaw & Co
New York
– -$221K -4,741 Closed
EFM
154
E Fund Management
China
– -$203K -4,369 Closed
Handelsbanken Fonder
155
Handelsbanken Fonder
Sweden
– -$200K -4,300 Closed
SWA
156
Sutton Wealth Advisors
Florida
– -$23.7K -509 Closed
3 4 5 6
7